Philippe Le Corre, CEO of G-ray Medical, stated: “This milestone enables us to demonstrate the huge potential of our latenium detectors with our first high resolution images.”
G-ray Switzerland SA, a Neuchâtel start-up, is currently developing ultra-high performance detectors dedicated to medical applications (in particular mammography). These ultra-high performance detectors will be developed in partnership with CSEM, based on G-ray’s revolutionary latenium technology.
Mario El-Khoury, CEO at CSEM, added: “The main challenge is now miniaturising both the sensor’s pixels and the system’s energy consumption, whilst offering very high-quality X-ray imaging for new generations of medical imaging solutions.”
Since the beginning of the 21st century, there has been a worrying increase in cases of breast cancer among young women. To maximise the chances of recovery of this frequent cancer, an early and reliable diagnosis of the disease is crucial. G-Ray Medical intends to offer the medical world a new generation of X-ray imagers based on its latenium electronic technology. A specific development is on-going with CSEM G-ray to produce the first latenium-based medical detector, planned to be completed by end of 2019.